These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 25056375)
1. Evidence for molecular differences in prostate cancer between African American and Caucasian men. Khani F; Mosquera JM; Park K; Blattner M; O'Reilly C; MacDonald TY; Chen Z; Srivastava A; Tewari AK; Barbieri CE; Rubin MA; Robinson BD Clin Cancer Res; 2014 Sep; 20(18):4925-34. PubMed ID: 25056375 [TBL] [Abstract][Full Text] [Related]
2. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. Fontugne J; Cai PY; Alnajar H; Bhinder B; Park K; Ye H; Beg S; Sailer V; Siddiqui J; Blattner-Johnson M; Croyle JA; Noorzad Z; Calagua C; MacDonald TY; Axcrona U; Bogaard M; Axcrona K; Scherr DS; Sanda MG; Johannessen B; Chinnaiyan AM; Elemento O; Skotheim RI; Rubin MA; Barbieri CE; Mosquera JM JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35050902 [TBL] [Abstract][Full Text] [Related]
3. SPOP mutations in prostate cancer across demographically diverse patient cohorts. Blattner M; Lee DJ; O'Reilly C; Park K; MacDonald TY; Khani F; Turner KR; Chiu YL; Wild PJ; Dolgalev I; Heguy A; Sboner A; Ramazangolu S; Hieronymus H; Sawyers C; Tewari AK; Moch H; Yoon GS; Known YC; Andrén O; Fall K; Demichelis F; Mosquera JM; Robinson BD; Barbieri CE; Rubin MA Neoplasia; 2014 Jan; 16(1):14-20. PubMed ID: 24563616 [TBL] [Abstract][Full Text] [Related]
4. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723 [TBL] [Abstract][Full Text] [Related]
5. Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Bhalla R; Kunju LP; Tomlins SA; Christopherson K; Cortez C; Carskadon S; Siddiqui J; Park K; Mosquera JM; Pestano GA; Rubin MA; Chinnaiyan AM; Palanisamy N Mod Pathol; 2013 Jun; 26(6):835-48. PubMed ID: 23348902 [TBL] [Abstract][Full Text] [Related]
6. SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion. Huang KC; Evans A; Donnelly B; Bismar TA Pathol Oncol Res; 2017 Apr; 23(2):399-407. PubMed ID: 27738792 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India. Ateeq B; Kunju LP; Carskadon SL; Pandey SK; Singh G; Pradeep I; Tandon V; Singhai A; Goel A; Amit S; Agarwal A; Dinda AK; Seth A; Tsodikov A; Chinnaiyan AM; Palanisamy N Prostate; 2015 Jul; 75(10):1051-62. PubMed ID: 25809148 [TBL] [Abstract][Full Text] [Related]
8. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes. Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175 [TBL] [Abstract][Full Text] [Related]
9. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue. Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy. Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication. Abdelsalam RA; Khalifeh I; Box A; Kalantarian M; Ghosh S; Abou-Ouf H; Lotfi T; Shahait M; Palanisamy N; Bismar TA J Cancer Res Clin Oncol; 2020 Jul; 146(7):1701-1709. PubMed ID: 32350606 [TBL] [Abstract][Full Text] [Related]
12. Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer. Bismar TA; Yoshimoto M; Duan Q; Liu S; Sircar K; Squire JA Histopathology; 2012 Mar; 60(4):645-52. PubMed ID: 22260502 [TBL] [Abstract][Full Text] [Related]
13. Molecular alterations in prostate cancer and association with MRI features. Lee D; Fontugne J; Gumpeni N; Park K; MacDonald TY; Robinson BD; Sboner A; Rubin MA; Mosquera JM; Barbieri CE Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):430-435. PubMed ID: 28762374 [TBL] [Abstract][Full Text] [Related]
14. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer. Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression. Han B; Mehra R; Lonigro RJ; Wang L; Suleman K; Menon A; Palanisamy N; Tomlins SA; Chinnaiyan AM; Shah RB Mod Pathol; 2009 Aug; 22(8):1083-93. PubMed ID: 19407851 [TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer. Leinonen KA; Saramäki OR; Furusato B; Kimura T; Takahashi H; Egawa S; Suzuki H; Keiger K; Ho Hahm S; Isaacs WB; Tolonen TT; Stenman UH; Tammela TL; Nykter M; Bova GS; Visakorpi T Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2333-44. PubMed ID: 24083995 [TBL] [Abstract][Full Text] [Related]
17. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence. Grupp K; Diebel F; Sirma H; Simon R; Breitmeyer K; Steurer S; Hube-Magg C; Prien K; Pham T; Weigand P; Michl U; Heinzer H; Kluth M; Minner S; Tsourlakis MC; Izbicki JR; Sauter G; Schlomm T; Wilczak W Prostate; 2013 Nov; 73(15):1690-8. PubMed ID: 23843146 [TBL] [Abstract][Full Text] [Related]
18. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. Rosen P; Pfister D; Young D; Petrovics G; Chen Y; Cullen J; Böhm D; Perner S; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S Urology; 2012 Oct; 80(4):749-53. PubMed ID: 22950997 [TBL] [Abstract][Full Text] [Related]
19. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location. Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432 [TBL] [Abstract][Full Text] [Related]
20. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Magi-Galluzzi C; Tsusuki T; Elson P; Simmerman K; LaFargue C; Esgueva R; Klein E; Rubin MA; Zhou M Prostate; 2011 Apr; 71(5):489-97. PubMed ID: 20878952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]